GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.7743 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.8835 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FABP3, FABP4, FLT3, GLO1, HASPIN, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MAOA, MET, MMP1, MMP12, MMP2, MMP9, NISCH, PHF8, PIM1, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
9.92708 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, IGF1R, KDR, KIT, MET, SRC |
8.39032 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, IGF1R, KDR, KIT, MET, SRC |
8.34014 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FABP3, GLO1, NISCH, PIM1, PPARA, TYR, XDH |
7.94825 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
7.94825 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, CA12, CA2, CA7, CDK6, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD17B1, HSD17B2, KDR, KIT, MAOA, MET, NISCH, PPARA, PRKCA, SRC, TNKS, TNKS2, XDH |
7.34956 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TNKS |
7.29616 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FABP3, FABP4, FLT3, GLO1, HASPIN, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MAOA, MET, MMP1, MMP2, PHF8, PIM1, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
7.09794 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FABP3, FABP4, HSD11B1, HSD17B1, HSD17B2, KIT, MET, PPARA |
7.07395 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PRKCA, SRC, TNKS, TOP2A |
6.91915 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD11B1, HSD17B1, HSD17B2, MAOA, PHF8, TYR, XDH |
6.83251 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP3, HSD17B2, IGF1R, MMP2, MMP9, PPARA, RORC, SRC, TYR |
6.68846 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, KIT, MMP2, PPARA, PRKCA, RORC, SRC, TYR |
6.68237 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, DYRK3, F3, FLT3, GLO1, HCAR2, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PRKCA, SRC, TOP2A, XDH |
6.2347 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
6.16324 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, DYRK3, F3, FLT3, GLO1, HCAR2, IGF1R, KDR, KIT, MET, MMP9, PIM1, PRKCA, SRC, TOP2A, XDH |
6.12837 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2, NISCH |
6.09532 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CLK1, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
5.99477 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TNKS |
5.96342 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, RORC, SRC, TYR |
5.71626 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APEX1, AURKB, AXL, CA2, CA9, CBR1, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DYRK1A, DYRK1B, DYRK3, FABP4, FLT3, GLO1, HSD11B1, HSD17B2, KDR, KIT, MET, MMP2, MMP9, PHF8, PIM1, PPARA, PRKCA, RORC, SRC, TNKS2, TOP2A, TYR |
5.44552 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APEX1, AXL, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, KIT, MMP2, MMP9, PPARA, PRKCA, RORC, SRC, TYR |
5.42786 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.34428 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, CA2, CA7, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DYRK1A, DYRK1B, DYRK2, F3, FABP3, FLT3, HCAR2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
5.12535 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
5.09283 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, CDK6, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, NISCH, PRKCA, SRC |
5.00073 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HCAR2, HSD11B1, HSD17B1, HSD17B2, PRKCA |
4.98816 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
4.98607 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, FLT3, HCAR2, KDR, KIT, MET, MMP12, MMP9, PRKCA, SRC, TNKS, TNKS2, XDH |
4.9195 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, CDK6, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TNKS, XDH |
4.9195 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, FLT3, HCAR2, KDR, KIT, MET, MMP12, MMP9, PRKCA, SRC, TNKS, TNKS2, XDH |
4.90569 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, DYRK3, F3, FLT3, GLO1, HCAR2, IGF1R, KDR, MMP9, PIM1, PRKCA, SRC, TOP2A, XDH |
4.90569 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.87275 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.72117 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, CBR1, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FABP3, FABP4, FLT3, GLO1, HASPIN, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NISCH, PHF8, PIM1, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
4.62927 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, NISCH, PRKCA, SRC |
4.61312 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, CDK6, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, NISCH, PRKCA, SRC |
4.61312 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, CDK6, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, NISCH, PRKCA, SRC |
4.60295 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, CDK6, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TNKS, XDH |
4.60295 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, KIT, MMP9, SRC |
4.60282 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
4.60236 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, CBR1, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FABP3, FABP4, FLT3, GLO1, HASPIN, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MAOA, MET, MMP1, MMP12, MMP2, MMP9, NISCH, PHF8, PIM1, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
4.59186 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.57622 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CDK6, CNR1, DRD1, HCAR2, KDR, SRC, TNKS, TNKS2 |
4.50291 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 |
4.47658 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DYRK1A, DYRK2, DYRK3, F3, FLT3, HCAR2, IGF1R, KDR, KIT, MET, MMP12, MMP9, NISCH, PRKCA, SRC, TNKS, TNKS2, XDH |
4.47658 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DYRK1A, DYRK2, DYRK3, F3, FLT3, HCAR2, IGF1R, KDR, KIT, MET, MMP12, MMP9, NISCH, PRKCA, SRC, TNKS, TNKS2, XDH |
4.36557 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, KDR, SRC |
4.32128 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, DYRK3, GLO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PRKCA, SRC |
4.30983 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, CA2, CA7, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DYRK1A, DYRK1B, DYRK2, F3, FABP3, FABP4, FLT3, HCAR2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
4.30983 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FABP3, FABP4, KIT, MET, PPARA |
4.23716 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, FLT3, RORC, SRC, TYR |
4.21585 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, DYRK3, GLO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PRKCA, SRC |
4.06206 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DYRK1A, DYRK2, DYRK3, FABP3, FABP4, GLO1, HCAR2, IGF1R, KDR, KIT, MET, MMP12, MMP9, NISCH, PHF8, PIM1, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
4.06206 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
CLK1, CSNK2A1, DYRK1A, HASPIN, PRKCA, TNKS |
4.0484 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AURKB, AXL, CDK6, CLK1, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FLT3, GLO1, HASPIN, IGF1R, KDR, KIT, MAOA, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PRKCA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
4.02541 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DYRK1A, DYRK3, FABP3, FABP4, GLO1, IGF1R, KDR, KIT, MET, MMP12, MMP9, NISCH, PHF8, PIM1, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
3.95245 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
3.9489 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, AXL, CA2, CA7, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DYRK2, F3, HCAR2, IGF1R, KDR, KIT, MET, MMP12, MMP9, NISCH, PPARA, PRKCA, SRC |
3.89476 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
CLK1, CSNK2A1, DYRK1A, HASPIN, PRKCA, TNKS |
3.86481 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, FLT3, HCAR2, KIT, PPARA, RORC, SRC |
3.84594 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA |
3.63843 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, CNR1, CNR2, DRD1, KIT, NISCH |
3.58686 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, CNR1, CNR2, DRD1, KIT, NISCH |
3.58686 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.54681 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD1, HCAR2, TNKS, TNKS2 |
3.52739 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.50847 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.50847 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.50847 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.50847 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, CA2, CA9, CSNK2A1, CYP1A2, DRD1, FABP3, FLT3, IGF1R, KIT, MMP2, PPARA, SRC |
3.49463 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, FABP3, KDR, SRC |
3.45508 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, CLK1, DRD1, DYRK1A, PRKCA, SRC, TNKS |
3.40202 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP3A4, PHF8 |
3.376 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.33634 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, MAOA |
3.32193 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, DRD1, HASPIN, PRKCA |
3.26615 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, CDK6, CSNK2A1, CYP1B1, F3, FABP3, FLT3, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PRKCA, SRC, XDH |
3.25798 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, AXL, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, RORC, SRC |
3.22138 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, RORC |
3.21826 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD11B1, HSD17B2, KDR, KIT, PHF8, PPARA, SRC, TYR |
3.21325 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, KIT, PPARA, SRC |
3.21036 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.15486 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, CLK1, DRD1, DYRK1A, PRKCA, SRC, TNKS |
3.13614 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, CDK6, CYP1A1, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, RORC, SRC |
3.09928 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.05471 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.04862 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APEX1, AURKB, AXL, CA2, CA6, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DYRK2, F3, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PPARA, PRKCA, RORC, SRC, TOP2A, TYR |
3.04004 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
3.00848 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, DRD1, KDR, SRC |
2.92033 |
[BP] GO:0032787 |
None
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PPARA |
2.91662 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DYRK1A, KIT, PPARA, RORC, SRC, TOP2A |
2.9045 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDK6, CLK1, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FABP3, FABP4, FLT3, GLO1, HASPIN, HCAR2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MAOA, MET, MMP1, MMP12, MMP2, MMP9, NISCH, PHF8, PIM1, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.88652 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, DYRK3, GLO1, IGF1R, KDR, MMP9, PIM1, PRKCA, SRC |
2.84354 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
2.83291 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AXL, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, F3, FABP4, HSD17B2, IGF1R, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TNKS2, TYR |
2.81439 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, AXL, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DYRK1A, DYRK1B, FLT3, HSD11B1, HSD17B2, KDR, KIT, MMP9, PHF8, PIM1, PPARA, RORC, SRC, TYR |
2.79554 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PRKCA, SRC |
2.79344 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CDK6, CNR1, CNR2, CYP19A1, DYRK1A, DYRK3, F3, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PRKCA, SRC, XDH |
2.7668 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.73543 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, SRC, TNKS |
2.7218 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CDK6, CSNK2A1, F3, FLT3, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PRKCA |
2.71444 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, DYRK1A, DYRK2, DYRK3, F3, FLT3, IGF1R, KDR, KIT, MET, MMP9, PRKCA, SRC, XDH |
2.69546 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, CNR1, CNR2, DRD1, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TYR |
2.67586 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, MAOA, TYR |
2.63941 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.62755 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AXL, CSNK2A1, CYP1B1, F3, FLT3, KDR, KIT, MET, MMP12, MMP9, PRKCA, SRC, TNKS, TNKS2, XDH |
2.60128 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD1, F3, FABP4, KDR, MET, MMP12, PPARA, PRKCA |
2.56468 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, AURKB, AXL, CDK6, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PRKCA, SRC, TNKS, TNKS2, TOP2A |
2.49043 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, AURKB, AXL, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, DYRK2, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, RORC, SRC, TOP2A |
2.47632 |
[BP] GO:0030335 |
positive regulation of cell migration
|
DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PRKCA, SRC |
2.44331 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.41756 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, CNR1, CNR2, DRD1, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TYR |
2.38441 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, DRD1, FLT3, RORC, SRC |
2.33595 |
[BP] GO:2000147 |
positive regulation of cell motility
|
DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PRKCA, SRC |
2.33595 |
[BP] GO:0050994 |
None
|
ADORA1, CNR1, HCAR2, PPARA |
2.3349 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.32238 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, AURKB, AXL, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DYRK1A, DYRK2, DYRK3, F3, FABP4, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP2, MMP9, PPARA, PRKCA, SRC, TNKS, TNKS2, XDH |
2.32191 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.32191 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.31732 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.29778 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.28335 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PRKCA, SRC |
2.26938 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, MAOA |
2.24081 |
[BP] GO:2001251 |
None
|
PHF8, SRC, TNKS, TNKS2, TOP2A |
2.23658 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PIM1, PPARA, TYR |
2.23658 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AXL, CNR1, CSNK2A1, CYP1B1, F3, FABP4, FLT3, KDR, KIT, MET, MMP12, MMP2, MMP9, PRKCA, SRC, TNKS, TNKS2, XDH |
2.22717 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP3A4, MAOA |
2.18789 |
[BP] GO:0040017 |
positive regulation of locomotion
|
DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PRKCA, SRC |
2.16729 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, SRC |
2.16426 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, HASPIN, TNKS, TNKS2 |
2.16426 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.13779 |
[BP] GO:0050995 |
None
|
ADORA1, CNR1, HCAR2 |
2.13008 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.11412 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.11262 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.10239 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, DRD1, IGF1R, MMP2, MMP9, RORC, SRC |
2.10239 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.08739 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.08739 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.08739 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.08739 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.08739 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, SRC |
2.07153 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, DRD1 |
2.06317 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.06317 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.0511 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.0511 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, SRC |
2.0511 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.04732 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, SRC |
2.0352 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AURKB, DRD1, DYRK1A, DYRK1B, DYRK2, F3, FABP3, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, PHF8, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
2.02982 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, AURKB, AXL, CDK6, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, MMP1, MMP2, PHF8, PIM1, PRKCA, SRC, TNKS, TNKS2, TOP2A |
2.00324 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, AURKB, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, F3, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, PHF8, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
2.00193 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, APEX1, AURKB, AXL, CA1, CA2, CA4, CA5A, CA5B, CA6, CBR1, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FABP3, FABP4, FLT3, GLO1, HASPIN, IGF1R, KDR, KIT, MAOA, MMP12, MMP2, MMP9, NISCH, PHF8, PIM1, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.62809 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, APEX1, AURKB, AXL, CA1, CA2, CA4, CA5A, CA5B, CA6, CA9, CBR1, CDK6, CLK1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FABP3, FABP4, FLT3, GLO1, HASPIN, IGF1R, KDR, KIT, MAOA, MMP12, MMP2, MMP9, NISCH, PHF8, PIM1, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.08739 |
[CC] GO:0043231 |
intracellular membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, APEX1, AURKB, CA4, CA5A, CA5B, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FABP4, FLT3, GLO1, HASPIN, IGF1R, KDR, KIT, MAOA, MMP12, MMP2, PHF8, PIM1, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
1.61115 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, AURKB, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DYRK2, DYRK3, FABP3, FABP4, FLT3, GLO1, HSD11B1, HSD17B1, HSD17B2, KDR, KIT, MAOA, MMP2, MMP9, NISCH, PIM1, PRKCA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
1.34842 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, F3, FLT3, GLO1, HCAR2, HSD11B1, HSD17B2, IGF1R, KDR, KIT, MAOA, MET, MMP2, NISCH, PHF8, PIM1, PRKCA, SRC, TNKS, TNKS2, TYR |
1.28594 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.9574 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DYRK2, GLO1, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PRKCA, RORC, TNKS, TYR, XDH |
16.5049 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FLT3, GLO1, HASPIN, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MAOA, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PRKCA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
16.5049 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FABP3, FABP4, FLT3, GLO1, HASPIN, HSD17B1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NISCH, PHF8, PIM1, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
14.7276 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.1086 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.8835 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CLK1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PPARA, PRKCA, SRC, TOP2A |
9.32096 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, IGF1R, KDR, KIT, MET, SRC |
8.45827 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 |
8.41126 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
8.30879 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD11B1, HSD17B1, HSD17B2, MAOA, PHF8, TYR, XDH |
8.10187 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC |
7.94825 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DYRK2, DYRK3, GLO1, KIT, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PRKCA, RORC, TNKS, TNKS2, TOP2A, TYR, XDH |
7.79668 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1, MMP1, MMP12, MMP2, MMP9, PHF8, PPARA, PRKCA, RORC, TNKS |
7.41259 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
6.88908 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DYRK2, DYRK3, GLO1, KIT, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PRKCA, RORC, TNKS, TNKS2, TOP2A, TYR, XDH |
6.84852 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC |
6.84852 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, PHF8, XDH |
6.74504 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC |
6.29825 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TYR |
6.03356 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, PHF8, TYR |
5.68219 |
[MF] GO:0004712 |
protein serine/threonine/tyrosine kinase activity
|
AURKB, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3 |
5.42786 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC |
5.31459 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
5.26786 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, SRC |
5.11992 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, SRC |
4.9195 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.57622 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP3A4 |
4.4327 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.02541 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD17B1, HSD17B2, XDH |
3.88006 |
[MF] GO:0004674 |
protein serine/threonine kinase activity
|
AURKB, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, HASPIN, PIM1, PRKCA |
3.87734 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TOP2A |
3.84594 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TOP2A |
3.69596 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TOP2A |
3.65716 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PRKCA, SRC |
3.64133 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FABP3, FABP4, FLT3, HASPIN, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TOP2A, XDH |
3.45237 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.18748 |
[MF] GO:0043168 |
anion binding
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FABP3, FABP4, FLT3, HASPIN, HSD17B1, IGF1R, KDR, KIT, MET, NISCH, PIM1, PRKCA, SRC, TOP2A, XDH |
3.17729 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD17B1, HSD17B2 |
3.13502 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD17B1, SRC, XDH |
2.89157 |
[MF] GO:0000166 |
nucleotide binding
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TOP2A, XDH |
2.88429 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TOP2A, XDH |
2.88425 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.72386 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TOP2A |
2.72026 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TOP2A |
2.59861 |
[MF] GO:0017076 |
purine nucleotide binding
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TOP2A |
2.56462 |
[MF] GO:0032553 |
ribonucleotide binding
|
AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TOP2A |
2.55755 |
[MF] GO:0035173 |
histone kinase activity
|
AURKB, HASPIN, PRKCA |
2.41756 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.32191 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.32191 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, FLT3, IGF1R, KDR, MMP12, MMP9, NISCH, PIM1, PPARA, SRC |
2.28722 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ADORA1, AURKB, AXL, CDK6, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PRKCA, SRC, TOP2A |
2.24324 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.08739 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.08739 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, KIT, MET, PPARA, RORC |
2.0511 |